GAN & LEE PHARMACEUTICALS' THREE INNOVATIVE DRUGS: GZR18 INJECTION, GZR4 INJECTION, AND GZR101 INJECTION ACHIEVE PRIMARY ENDPOINTS IN PHASE 2 CLINICAL STUDIES

Reuters · 10/15 11:07

Please log in to view news